Duopharma Biotech Competitors and Similar CompaniesClear all

Duopharma Biotech's competitors and similar companies include Genentech, Cipla and Kadmon.

	Duopharma Biotech Duopharma Biotech is a pharmaceutical company that specializes in the manufacturing, research, development, and commercialization of generic drugs.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Kadmon Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
Founding Date	Founding Date 1979	Founding Date 1976	Founding Date 1935	Founding Date 2010
Type	Type Public	Type Subsidiary	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development holding company pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development holding company pharma
Locations	Locations Bandar Baru Bangi, MY HQ Klang, MY Shah Alam, MY Quezon City, PH Singapore, SG	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations New York, US HQ Cambridge, US South Brunswick Township, US Warrendale, US
Employees	Employees N/A	Employees 18,077	Employees 27,764	Employees 44
Financial
Revenue (est.)	Revenue (est.) RM931.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) $8.3m (FY, 2020)
Cost of goods	Cost of goods RM513.5m (FY, 2025)	Cost of goods N/A	Cost of goods ₹97.2b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit RM418.5m (FY, 2025)	Gross profit N/A	Gross profit ₹184.4b (FY, 2026)	Gross profit N/A
Net income	Net income RM87.5m (FY, 2025)	Net income N/A	Net income ₹38.7b (FY, 2026)	Net income ($108.9m) (FY, 2020)